← Back to Clinical Trials
Recruiting NCT04921592

NCT04921592 Upper Extremity Training for Chronic Cervical Spinal Cord Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04921592
Status Recruiting
Phase
Sponsor Kessler Foundation
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2021-06-14
Primary Completion 2027-06-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
upper extremity stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2021-06-14 with a primary completion date of 2027-06-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is to understand how the combination of activity-based recovery training and targeted spinal cord transcutaneous stimulation (scTS) can improve participants' ability to use their hand, arms, and core.

Eligibility Criteria

Inclusion Criteria: * 18 years of age. * spinal cord injury for greater than or equal to 6 months. * spinal cord injury at a cervical neurologic level of injury. Exclusion Criteria: * ventilator dependent. * history of fractures. * pressure sore or skin issues. * history of illicit drug abuse. * history of cardiac, respiratory, bladder, renal or other medical disorder unrelated to spinal cord injury. * bladder Botox injections less than 12 months prior. * muscle Botox injections less than 12 months prior. * colostomy bag or urostomy. * implanted pump (i.e., baclofen pump, pain pump, etc). * If I am female: I am pregnant at the time of enrollment or planning to become pregnant during the course of the study. * unable to wean from anti-spasticity medication. * contraindications to MRI imaging (pacemaker, metallic foreign body, aneurysm clip, etc.)

Contact & Investigator

Central Contact

LeighAnn Martinez, BA

✉ lmartinez@kesslerfoundation.org

📞 973.324.3557

Principal Investigator

Gail F Forrest, PhD

PRINCIPAL INVESTIGATOR

Kessler Foundation

Frequently Asked Questions

Who can join the NCT04921592 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04921592 currently recruiting?

Yes, NCT04921592 is actively recruiting participants. Contact the research team at lmartinez@kesslerfoundation.org for enrollment information.

Where is the NCT04921592 trial being conducted?

This trial is being conducted at West Orange, United States.

Who is sponsoring the NCT04921592 clinical trial?

NCT04921592 is sponsored by Kessler Foundation. The principal investigator is Gail F Forrest, PhD at Kessler Foundation. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology